F Nager

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Infective Endocarditis

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

Epidemiology of bacterial endocarditis in The Netherlands. I. Patient characteristics

New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings

Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary The Task Force on Infective Endocarditis of the European Society of Cardiology

Q Fever Endocarditis in Israel and a Worldwide Review

Effect of antibiotic treatment on vegetation size and complication rate in infective endocarditis

Prediction of Rapid versus Prolonged Healing of Infective Endocarditis by Monitoring Vegetation Size

Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms

Simplified assessment of segmental colonic transit

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease

Q Fever

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2015 ESC Guidelines for the management of infective endocarditis

Estimation of gastric residence time of the heidelberg capsule in humans: Effect of varying food composition

[Heart valve replacement in active infectious endocarditis].

The antiarrhythmic effects of controlled release disopyramide phosphate and long acting propranolol in patients with ventricular arrhythmias

[Endocarditis with unusual causative agents].

[Changes in infectious endocarditis in 3 decades].